#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Sharon Mates Email
Founder, Chairman & CEO . Intra-Cellular Therapies
How to contact Sharon Mates
Join and see Sharon's contact info for free!Current Roles
Employees:
541Revenue:
$70.6MAbout
Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, leveraging technology from the lab of Nobel laureate Dr. Paul Greengard, for the treatment of neuropsychiatric and neurodegenerative diseases. The Company is developing its lead drug candidate, lumateperone, a first-in-class molecule, which is in Phase 3 clinical development for the treatment of schizophrenia, bipolar depression, and agitation associated with dementia, including Alzheimer's disease. The Company is also utilizing its phosphodiesterase (PDE) platform and other proprietary chemistry platforms to develop drugs for the treatment of CNS and other disorders. The lead compound in the PDE platform, ITI-214, a PDE1 inhibitor is being developed for the treatment of CNS and non-CNS indications. Use link below for a listing of Job Opportunities: https://www.linkedin.com/jobs/search/keywords=intra-cellular%20therapies&location=United%20States&locationId=us%3A0Intra-Cellular Therapies Address
430 East 29th StreetNew York, NY
United States